Week in Review: August 12–16

Engineered immune cells attack tumors; a mouth microbe that can cause cancer; HIV may heighten cocaine’s high; craving high-fat foods

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, ED UTHMANCombining cellular reprogramming approaches with a method to genetically modify patients’ own T cells, scientists have come up with a way to mass-produce an unlimited quantity of cancer-fighting cells.

Memorial Sloan-Kettering Cancer Center’s Michel Sadelain and his colleagues this week showed that these genetically engineered cells, which resemble natural immune cells, effectively eliminated tumors in a mouse model of lymphoma. With this method, Sadelain told The Scientist, “there’s flexibility here for redirecting their specificity towards anything that you want.”

The next step, he added, is to find out more about the biological nature of these T cell-like cells and assess their safety.

FLICKR, GÁLIBOA Gram-negative microbe typically found in the oral cavity can spur inflammatory and oncogeneic responses in the gut, causing colorectal cancer. Two separate teams this week identified how Fusobacterium nucleatum promotes cancer development, and pointed to potential diagnostic and therapeutic applications. The researchers cautioned, though, that targeting F. nucleatum alone is unlikely to be useful. “We have evolved beyond the stage of ‘one bacteria, one disease.’ I think we will still find those keystone pathogens that play a key role in those diseases, [but] with microbiome studies . . . mechanistic studies are very important,” Case Western Reserve University’s Yiping Han told The Scientist.

FLICKR, UKHOMEOFFICEAn HIV transcription protein could help heighten cocaine’s high, a rat study has found. While all mice given the drug showed an affinity for it, those expressing the virus’s Tat gene showed the greatest propensity to seek out the stimulant. Additionally, these mice were more hyperactive when on the substance than those without the protein. “Exposure to Tat protein may increase vulnerability not only to the rewarding effects of drugs of abuse, but could increase vulnerability to relapse,” study coauthor Jay McLaughlin, from the Torrey Pines Institute for Molecular Studies, told The Scientist. The researchers noted that their findings could help explain why humans who are infected with HIV and use drugs tend to suffer more neurological and cognitive decline than those who are not infected or don’t use.

WIKIMEDIA, LOTUS HEADSnarled communication between the brain and the gut may be one reason high-fat foods seem highly addictive, researchers have found. Yale School of Medicine’s Ivan de Araujo this week showed that the lipid oleoylethanolamide affects dopamine signaling emanating from the gut, and that a chronic high-fat diet suppresses production of the lipid. Diminished supplies of oleoylethanolamide cause the brain to be essentially “blind to the presence of calories in the gut,” Araujo told The Scientist. When oleoylethanolamide was restored in mice fed a high-fat diet, so too was their dopamine signaling.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies